Efficacy of Alternative and Other Treatments According to GRADE* Ranking:
Turmeric and Curcumin [1, 13, 14, 15, 16, 17,1 8, 21]:
Recommendation: Strongly in Favor (Early laboratory studies show that turmeric may be of benefit in the treatment of Alzheimers. However, further studies are needed)
Grade of Evidence: Moderate level of evidence
Gotu Kola (Centella Asiatica, Hydrocotyle Asiatica)[1, 7, 8, 9, 10, 11, 12]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: Weakly In Favor (A few clinical trials have shown that Gotu Kola may be helpful in the treatment of Alzheimers Disease. However, further research is needed)
Grade of Evidence: Low level of evidence
Gingko [1, 2, 3, 4, 5]:
Recommendation: No Recommendation (A few major studies show that ginkgo does not help improve cognitive function in mild Alzheimer's disease)
Grade of Evidence: Low level of evidence
Vitamin E high dosage [19, 20]:
Recommendation: Weakly in favour ( some well designed studies have found a significant benefit in decrease in the decline of memory function in patients taking high dosage on vitamin E high dosage)
Level of evidence: Moderate level of evidence
Alpha-lipoic acid [6, 22, 23]:
Recommendation: Weakly in favour ( some studies have found a significant benefit in decrease in the decline of memory function in patients taking alpha-lipoic acid)
Level of evidence: Low level of evidence
Omega-3 Fatty Acid Supplement [24, 25, 26]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: Weakly in favor (a few Studies have shown that omega-3 fatty acid supplements may be beneficial to those that have Alzheimer's. However some studies have shown no benefit in taking the supplement, more studies are needed.)
Level of evidence: Very low level of evidence
Vitamin D3 [27, 28, 29, 30, 31, 32, 33]:
Recommendation: Weakly in Favor (Evidence shows that Vitamin D may help improve cognitive function in mild Alzheimers disease and low concentration of circulating vitamin D is associated with a higher incidence of developing Alzheimers disease)
Grade of Evidence: Low level of evidence
Selenium [34, 35, 36]:
Recommendation: Weakly in Favor (Current evidence does not indicate it is an effective treatment for AD but some evidence shows selenium to be an effective preventive strategy for the development of AD, however it is likely to be useful in conjunction with other treatments)
Grade of Evidence: Very low level of evidence
Vitamin C [37, 38, 39]:
Recommendation: No recommendation (Studies on the effect of Vitamin C on Alzheimer's Disease have found it to be preventative but not effective as a treatment of AD on its own, more research is needed.)
Grade of Evidence: Very low level of evidence
Zinc [40, 41, 42, 43, 44]:
Recommendation: No recommendation (Although Zinc has been found to be deficient in patients with AD and a few limited studies have found slight benefits in taking Zinc, there is insufficient evidence to validate a recommendation for taking Zinc for the treatment of AD. Further research is needed)
Grade of Evidence: Low level of evidence
Coenzyme Q10 [45, 46, 47, 48]:
Recommendation: No recommendation (Coenzyme Q10 may be useful as a preventative treatment or treatment against Alzheimer's according to successful animal trials but human trials have not been successful.)
Grade of Evidence: Very low level of evidence
Citicoline [49, 50, 51, 52, 53, 54, 55, 56, 57]:
Recommendation: Strongly in favor (The present data indicate that citicoline (1,000 mg/day) is well tolerated and improves cognitive performance, cerebral blood perfusion and the brain bioelectrical activity pattern in AD )
Grade of Evidence: Moderate level of evidence
Methyltetrahydrofolate (5 MTHF) [58, 59, 60, 61, 62, 63]:
Recommendation: Weakly in favor (5 MTHF has been found to reduce the homocysteine ( tHcy) levels, high tHcy levels are a significant risk factor for AD. More studies are needed)
Grade of Evidence: Low level of evidence
Choline Alfoscerate [64]:
Recommendation: No recommendation (One study has found Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate however more research is needed to validate these positive findings)
Grade of Evidence: Very low level of evidence
N-Acetylcystine [65, 66, 67, 68]:
Recommendation: No recommendation (A few limited studies have shown a favourable change using NAC treatment on nearly every outcome measure on AD patients )
Grade of Evidence: Very low level of evidence
Probiotics [69, 70, 71, 72, 73]:
Weakly in favor (A few clinical trials have shown that Probiotics may be helpful in the treatment of Alzheimer's Disease. However, further research is needed)
Grade of Evidence: Very low level of evidence
Pyrroloquinoline quinone (PQQ) [74, 75, 76, 77, 78]:
Recommendation: No recommendation (A few limited clinical trials have shown that Pyrroloquinoline quinone (PQQ) may be helpful in the treatment of Alzheimer's Disease. However, further research is needed)
Grade of Evidence: Very low level of evidence
Tryptophan [79, 80, 81, 82, 83, 84, 85, 86]:
Recommendation: Weakly in favor(Tryptophan is an essential amino acid required to synthesize proteins which is found to be depleted in AD, research indicates it is helpful in aiding sleep and assisting in neurological repair and maintenance. More research is needed. Should be taken at night.)
Grade of Evidence: Very low level of evidence
Vitamin K2 [87, 88, 89, 90]:
Recommendation: Weakly in favor (Recent research has indicated Vitamin K insufficiency could not only be a risk factor for AD, but could also contribute to its accelerated progression, more research is needed)
Grade of Evidence: Very low level of evidence
Vitamin B1 [91, 92, 93]:
Recommendation: Weakly in favor (Whilst there are some good studies implicating the benefits of Vitamin B complex in the improvement for cognitive function of some patients with neurodegenerative diseases only one study implicated the same for Vitamin B1, more research is needed)
Grade of Evidence: Low level of evidence
Vitamin B5 [94, 95, 96]:
Recommendation: Weakly in favor (Whilst there are some good studies implicating the benefits of Vitamin B complex (including Vitamin B5) in the improvement for cognitive function of some patients with neurodegenerative diseases there only indirect studies implicating the same for Vitamin B5 on its own, however the Vitamin B complex benefit would infer a benefit, more research is needed)
Grade of Evidence: Very low level of evidence
Pyridoxal 5'-Phosphate [97, 98]:
Recommendation: No recommendation (There is insufficient evidence to support any claims that P-5-P is able to help treat Alzheimer's. More studies are needed)
Grade of Evidence: Very low level of evidence
Methylcobalamin [99, 100, 101, 102]:
Recommendation: No recommendation (There is insufficient evidence to support any claims that Methylcobalamin is able to help treat Alzheimer's. More studies are needed)
Grade of Evidence: Very low level of evidence
Vitamin E [103, 104, 105, 106]:
Recommendation: Weakly in favor (A few well designed studies suggests a possible benefit of vitamin E for the treatment of AD. Use of vitamin E and vitamin C supplements in combination is associated with reduced prevalence and incidence of AD)
Grade of Evidence: Low level of evidence
Aceyl-L-Carnitine [107, 108, 109, 110, 111]:
Recommendation: Weakly in favor (Acetyl-l-carnitine showed a slower rate of deterioration of AD and significant improvement in memory tests in these listed studies. Although a Cochcrane review of 2003 found insufficient evidence of benefit, more tests are needed.)
Grade of Evidence: Very low level of evidence
Resveratrol [112, 113, 114, 115, 116, 117, 118, 119]:
Recommendation: Strongly in favor (Studies have implicated resveratrol as a benefit in the treatment of AD with no marked toxicity)
Grade of Evidence: Moderate level of evidence
Sleep 8 Hours [120, 121, 122, 123, 124, 125, 126]:
Recommendation: Strongly in favor (Recent studies have found the glymphatic system is the functional waste clearance pathway for the central nervous system, and is largely disengaged during wakefulness. Researchers have noted increased sleep can lead to an increased clearance of amyloid deposits. More research on sleep is needed)
Grade of Evidence: Moderate level of evidence
Pomegranate [127, 128, 129, 130, 131]:
Recommendation: Weakly in favor (Accumulating research offers reasonable evidence that routine supplementation with pomegranate juice or extract is a powerful antioxidant and may protect against Alzheimer’s and well-designed research studies on mice clearly shows its ability to reduce toxic amyloid load. It has been shown to have low toxicity and only rare side effects)
Grade of Evidence: Low level of evidence
Melatonin [132, 133, 134, 135, 136, 137]:
Recommendation: Weakly in favor (A few well designed studies indicated melatonin improved sleep quality and cognitive parameters, more sleep may enable the glymphatic system system to remove more amyloid build up)
Grade of Evidence: Low level of evidence
Vitamin B6 [138, 139, 140, 141, 142]:
Recommendation: Weakly in favor (A few well-defined studies have shown treatment with Vitamin B group (including Vitamin b6 ) slowed atrophy in AD patients. Other early studies have not yielded any significant improvements.)
Grade of Evidence: Low level of evidence
Zinc Picolinate [143]:
Recommendation: No recommendation (A few studies have found benefits of using Zinc picolinate in animals studies indicating a reduction in oxidative stress and inflammation, but human studies need to be done before giving a conclusive recommendation.)
Grade of Evidence: Very low level of evidence
Coconut Oil [144, 145, 146]:
Recommendation: Weakly in favor (Coconut oil contains a high percentage of a molecule called medium-chain triglycerides (MCT) which is converted to ketones and can then cross the blood-brain barrier and can be used as an energy source for the neurons. In AD insulin is depleted, insulin is needed for the transport of glucose into the cells and a lack of utilization of glucose leads to death of the neurons. But with ketones they can cross into the cells without insulin, thus coconut oil converted to ketones feeds and sustains the neurons.)
Grade of Evidence: Low level of evidence
Intermittent Fasting 12 Hours (IF12) - 8pm to 8am [147, 148, 149, 150, 151, 152, 153, 154, 155, 156]:
Recommendation: Weakly in favor (There is new evidence in some limited studies suggesting that healthy calorie intake with limited fasting increases lifespan and may reduce neurological decline)
Grade of Evidence: Low level of evidence
Calorie Restriction Diet (CREAHR) - Average Healthy Requirements [147, 148, 149, 150, 151, 152, 153, 154, 155, 156]:
Recommendation: Weakly in favor (There is new evidence in some limited studies suggesting that healthy calorie intake with limited fasting increases lifespan and may reduce neurological decline)
Grade of Evidence: Low level of evidence
Intermittent Fasting (IF3BB) - No Eating 3 Hours Before Bedtime [147, 148, 149, 150, 151, 152, 153, 154, 155, 156]:
Recommendation: Weakly in favor (There is new evidence in some limited studies suggesting that healthy calorie intake with limited fasting increases lifespan and may reduce neurological decline)
Grade of Evidence: Low level of evidence
Pesco-Vegetarian Diet (Vegetarian With Fish) [147, 148, 157, 158, 159, 160]:
Recommendation: Weakly in favor (Numerous studies have implicated a vegetarian diet with fish had a protective effect on neurological decline and associated diseases)
Grade of Evidence: Low level of evidence
Gluten Free Diet [161, 162]:
Recommendation: No recommendation (There is insufficient evidence to validate a gluten free diet as a therapy for AD)
Grade of Evidence: Very low level of evidence
*www.gradeworkinggroup.org
Summary References
Treatments:
1. Ades T, Alteri R, Gansler T, Yeargin P, "Complete Guide to Complimentary & Alternative Cancer Therapies", American Cancer Society, Atlanta USA, 2009
2. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/ginkgo
3. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-ginkgo.html
4. http://nccam.nih.gov/news/newsletter/2010_may/ginkgostudy.htm
5. https://nccih.nih.gov/news/2008/111808.htm
6. http://www.ncbi.nlm.nih.gov/pubmed/18655815
7. Winston, D., Maimes, S., Adaptogens: Herbs For Strength, Stamina, and Stress Relief, 2007, pp. 226-7
8. "A Double-Blind, Placebo-Controlled Study on the Effects of Gotu Kola (Centella asiatica) on Acoustic Startle Response in Healthy Subjects". Journal of Clinical Psychopharmacology. 20(6):680-684, December 2000. Bradwejn, Jacques MD, FRCPC *; Zhou, Yueping MD, PhD ++; Koszycki, Diana PhD *; Shlik, Jakov MD, PhD
9. B. M. Hausen (1993) "Centella asiatica (Indian pennywort), an effective therapeutic but a weak sensitizer." Contact Dermatitis 29 (4), 175–179 doi:10.1111/j.1600-0536.1993.tb03532.x
10. Cataldo, A., Gasbarro, V., et al., "Effectiveness of the Combination of Alpha Tocopherol, Rutin, Melilotus, and Centella asiatica in The Treatment of Patients With Chronic Venous Insufficiency", Minerva Cardioangiology, 2001, Apr; 49(2):159-63
11. http://en.wikipedia.org/wiki/Gotu_kola#Medicinal_effects
12. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/gotu-kola
13. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/turmeric
14. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-turmeric.html
15. http://nccam.nih.gov/health/turmeric/index.htm
16. http://news.bbc.co.uk/2/hi/health/1668932.stm
17. http://www.mirror.co.uk/news/top-stories/2009/10/28/curry-kills-cancer-cells-and-other-health-benefits-of-the-nations-favourite-dish-115875-21779950/
18. http://clinicaltrials.gov/ct2/results?term=turmeric
19. http://jama.jamanetwork.com/article.aspx?articleid=1810379
20. http://www.drperlmutter.com/vitamin-e-exciting-news-alzheimers-patients/
21. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781139/
22. http://www.ncbi.nlm.nih.gov/pubmed/17982894
23. http://www.ncbi.nlm.nih.gov/pubmed/11395173
24. http://www.sciencedirect.com/science/article/pii/S0278584608001504
25. http://www.ncbi.nlm.nih.gov/pubmed/22002791
26. http://www.ncbi.nlm.nih.gov/pubmed/23481688
27. https://nutritionj.biomedcentral.com/articles/10.1186/s12937-015-0063-7
28. https://www.vitamindcouncil.org/health-conditions/alzheimers-disease/
29. https://nutritionj.biomedcentral.com/articles/10.1186/s12937-015-0063-7
30. http://www.neurology.org/content/early/2014/08/06/WNL.0000000000000755.short
31. http://www.alzheimersresearchuk.org/vitamin-d-deficiency-linked-to-dementia-risk/
32. http://www.webmd.com/alzheimers/news/20140806/low-vitamin-d-levels-may-boost-alzheimers-risk-study-finds
33. http://www.ncbi.nlm.nih.gov/pubmed/22536767
34. http://www.ncbi.nlm.nih.gov/pubmed/22536767
35. http://www.ncbi.nlm.nih.gov/pubmed/17272290
36. http://www.ncbi.nlm.nih.gov/pubmed/15207438
37. http://www.jbc.org/content/286/31/27559
38. http://lpi.oregonstate.edu/mic/vitamins/vitamin-C
39. http://www.ncbi.nlm.nih.gov/pubmed/22366772
40. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810325/
41. http://www.ncbi.nlm.nih.gov/pubmed/25835420
42. http://www.ncbi.nlm.nih.gov/pubmed/21949909
43. http://www.sciencedirect.com/science/article/pii/S0092867410009384
44. http://www.sciencedirect.com/science/article/pii/S0896627301003178
45. http://www.ncbi.nlm.nih.gov/pubmed/21799249
46. http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8893880&fileId=S1092852900020538
47. http://content.iospress.com/articles/journal-of-alzheimers-disease/jad110209
48. http://www.alzdiscovery.org/cognitive-vitality/report/coq10
49. http://stroke.ahajournals.org/content/42/1_suppl_1/S40.short
50. http://www.ncbi.nlm.nih.gov/pubmed/10669911
51. http://ww.ncbi.nlm.nih.gov/pmc/articles/PMC2695184/
52. http://www.ncbi.nlm.nih.gov/pubmed/15005642
53. http://www.life-enhancement.com/magazine/article/1004-alzheimers-patients-benefit-from-cdp-choline
54. http://www.medscape.com/viewarticle/780283
55. http://www.naturalmedicinejournal.com/journal/2010-06/citicoline-novel-therapeutic-agent-neuroprotective-neuromodulatory-and
56. http://www.alzheimersanddementia.com/article/S1552-5260(14)01407-1/fulltext
57. http://onlineresearchjournals.org/JMMSR/pdf/2013/feb/Milani.pdf
58. http://ajcn.nutrition.org/content/79/3/473.full
59. http://www.ncbi.nlm.nih.gov/pubmed/3735413
60. http://www.ncbi.nlm.nih.gov/pubmed/19661622
61. http://www.ncbi.nlm.nih.gov/pubmed/23099812
62. http://articles.mercola.com/sites/articles/archive/2013/06/03/vitamin-b.aspx
63. http://primarypsychiatry.com/l-methylfolate-methylcobalamin-and-n-acetylcysteine-in-the-treatment-of-alzheimeras-diseasearelated-cognitive-decline/
64. http://www.ncbi.nlm.nih.gov/pubmed/12637119
65. http://www.ncbi.nlm.nih.gov/pubmed/11673605
66. http://primarypsychiatry.com/l-methylfolate-methylcobalamin-and-n-acetylcysteine-in-the-treatment-of-alzheimeras-diseasearelated-cognitive-decline/
67. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967529/
68. https://www.ucsf.edu/news/2005/12/5361/key-brain-antioxidant-linked-alzheimers-and-parkinsons
69. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221920/
70. http://journal.frontiersin.org/article/10.3389/fneur.2014.00043/full
71. http://newsroom.ucla.edu/releases/changing-gut-bacteria-through-245617
72. http://www.alzheimersanddementia.com/article/S1552-5260(12)02523-X/fulltext
73. http://www.ncbi.nlm.nih.gov/pubmed/23500100
74. http://www.tandfonline.com/doi/abs/10.1080/10715760802677348?journalCode=ifra20
75. http://altmedrev.com/publications/14/3/268.pdf
76. http://www.jneurosci.org/content/12/6/2362
77. http://www.ncbi.nlm.nih.gov/pubmed/25018109
78. http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0109502
79. http://www.la-press.com/nutritional-aspect-of-tryptophan-metabolism-article-a3772
80. http://www.uofmhealth.org/health-library/hn-1000631
81. http://www.pnas.org/content/109/37/14912.long
82. http://www.pnas.org/content/87/7/2506.long
83. http://www.ncbi.nlm.nih.gov/pubmed/25547097
84. http://www.ncbi.nlm.nih.gov/pubmed/26667000
85. https://www.sciencedaily.com/releases/2016/04/160425161205.htm
86. http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=136411&fileId=S0033291702006906
87. http://www.ncbi.nlm.nih.gov/pubmed/26274973
88. http://www.ncbi.nlm.nih.gov/pubmed/19027415
89. http://www.lmreview.com/articles/view/Vitamin-K2-Essential-for-Prevention-of-Age-Associated-Chronic-Disease/
90. http://www.ncbi.nlm.nih.gov/pubmed?term=PMID%3A%2011461163
91. http://www.omicsonline.org/open-access/benefits-of-thiamin-vitamin-b-administration-in-neurodegenerative-diseases-may-be-due-to-both-the-coenzyme-and-noncoenzyme-roles-of-thiamin-2161-0460.1000173.php?aid=34970
92. http://www.ncbi.nlm.nih.gov/pubmed?term=PMID%3A%2011461163
93. http://www.pnas.org/content/110/23/9523.long
94. http://www.pnas.org/content/110/23/9523.long
95. http://lpi.oregonstate.edu/mic/vitamins/pantothenic-acid
96. http://ajcn.nutrition.org/content/92/2/330.short
97. https://pubchem.ncbi.nlm.nih.gov/compound/pyridoxal_phosphate
98. http://www.ncbi.nlm.nih.gov/pubmed/17504214
99. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875920/
100. http://primarypsychiatry.com/l-methylfolate-methylcobalamin-and-n-acetylcysteine-in-the-treatment-of-alzheimeras-diseasearelated-cognitive-decline/
101. http://www.biomedsearch.com/article/Alzheimers-disease-amnestic-mild-cognitive/181714351.html
102. http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=9049122&fileId=S1092852900027589
103. http://www.ncbi.nlm.nih.gov/pubmed/9110909
104. http://www.ncbi.nlm.nih.gov/pubmed/17203561
105. http://www.ncbi.nlm.nih.gov/pubmed/11342679
106. http://archneur.jamanetwork.com/article.aspx?articleid=785249
107. http://medind.nic.in/daa/t12/i1/daat12i1p208.pdf
108. http://www.ncbi.nlm.nih.gov/pubmed/1944900
109. http://www.ncbi.nlm.nih.gov/pubmed/12841930
110. http://www.ncbi.nlm.nih.gov/pubmed/12804452
111. http://www.webmd.com/vitamins-supplements/ingredientmono-834-acetyl-l-carnitine.aspx?activeingredientid=834&activeingredientname=acetyl-l-carnitine
112. http://www.medscape.com/viewarticle/851172
113. http://www.ncbi.nlm.nih.gov/pubmed/22211686
114. http://www.ncbi.nlm.nih.gov/pubmed/25525597
115. http://www.hindawi.com/journals/bmri/2014/350516/
116. http://www.ncbi.nlm.nih.gov/pubmed/23315270
117. http://www.ncbi.nlm.nih.gov/pubmed/20848560
118. http://onlinelibrary.wiley.com/wol1/doi/10.1002/biof.118/full
119. http://time.com/4032194/red-wine-alzheimers/
120. https://www.nih.gov/news-events/nih-research-matters/how-sleep-clears-brain
121. http://www.ncbi.nlm.nih.gov/pubmed/25947369
122. https://www.urmc.rochester.edu/labs/Nedergaard-Lab/projects/glymphatic_system
123. https://www.alz.washington.edu/NONMEMBER/FALL15/DIR/Iliff.pdf
124. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651462/
125. http://articles.mercola.com/sites/articles/archive/2013/10/31/sleep-brain-detoxification.aspx
126. http://archneur.jamanetwork.com/article.aspx?articleid=1915582
127. http://www.sciencedirect.com/science/article/pii/S0969996106002038
128. http://www.nature.com/pr/journal/v57/n6/abs/pr2005159a.html
129. http://onlinelibrary.wiley.com/doi/10.1111/j.1541-4337.2010.00131.x/full
130. http://www.ncbi.nlm.nih.gov/pubmed/11754562
131. http://www.ncbi.nlm.nih.gov/pubmed/19083391
132. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001215/
133. http://www.ncbi.nlm.nih.gov/pubmed/12019347
134. http://www.dynamicchiropractic.com/mpacms/dc/article.php?id=55987
135. http://www.jneurosci.org/content/17/5/1683.short
136. http://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.2003.01654.x/full
137. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418658/
138. http://www.ncbi.nlm.nih.gov/pubmed/23690582
139. http://www.pnas.org/content/110/23/9523.short
140. http://lpi.oregonstate.edu/mic/vitamins/vitamin-B6
141. http://mrcanu.pharm.ox.ac.uk/news/b-vitamins-slow-alzheimer%E2%80%99s-disease
142. http://www.express.co.uk/life-style/health/385884/Supplements-halt-Alzheimer-s-groundbreaking-dementia-prevention-treatment
143. http://www.jrnjournal.org/article/S1051-2276(10)00105-6
144. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731764/
145. http://www.journalijcms.com/sites/default/files/issue-files/0022.pdf
146. http://articles.mercola.com/sites/articles/archive/2013/11/07/peanut-butter-coconut-oil-alzheimers-detection.aspx
147. http://www.aging-us.com/article/NjJf3fWGKw4e99CyC
148. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947325
149. http://www.ncbi.nlm.nih.gov/pubmed/19075044
150. http://www.ncbi.nlm.nih.gov/pubmed/22932268
151. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832985
152. http://www.ncbi.nlm.nih.gov/pubmed/19590001
153. http://www.ncbi.nlm.nih.gov/pubmed/21402069
154. http://www.ncbi.nlm.nih.gov/pubmed/17374682
155. http://www.ncbi.nlm.nih.gov/pubmed/12771340
156. http://www.hindawi.com/journals/omcl/2016/4010357
157. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947325
158. http://www.ncbi.nlm.nih.gov/pubmed/12936945
159. http://www.ncbi.nlm.nih.gov/pubmed/8327020
160. http://www.ncbi.nlm.nih.gov/pubmed/18349528
161. https://www.sciencebasedmedicine.org/a-balanced-look-at-gluten-sensitivity/
162. http://www.ncbi.nlm.nih.gov/pubmed/23648697
Public Discussion
No discussions exist for this condition yet. You can be the first to create one!